Caglevic, C.; Contreras-Torrez, M.A.; Reyes-Cosmelli, F.; Uribe-Maturana, R.; Mahave, M.; Caire, N.; Villanueva-Olivares, L.; Cid, F.; Lladser, A.; Sapunar, J.
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review. Antibodies 2026, 15, 49.
https://doi.org/10.3390/antib15030049
AMA Style
Caglevic C, Contreras-Torrez MA, Reyes-Cosmelli F, Uribe-Maturana R, Mahave M, Caire N, Villanueva-Olivares L, Cid F, Lladser A, Sapunar J.
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review. Antibodies. 2026; 15(3):49.
https://doi.org/10.3390/antib15030049
Chicago/Turabian Style
Caglevic, Christian, Mario Alex Contreras-Torrez, Felipe Reyes-Cosmelli, Rodrigo Uribe-Maturana, Mauricio Mahave, Nicole Caire, Luis Villanueva-Olivares, Fernando Cid, Alvaro Lladser, and Jorge Sapunar.
2026. "Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review" Antibodies 15, no. 3: 49.
https://doi.org/10.3390/antib15030049
APA Style
Caglevic, C., Contreras-Torrez, M. A., Reyes-Cosmelli, F., Uribe-Maturana, R., Mahave, M., Caire, N., Villanueva-Olivares, L., Cid, F., Lladser, A., & Sapunar, J.
(2026). Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review. Antibodies, 15(3), 49.
https://doi.org/10.3390/antib15030049
